Substituted Pyrrolidine Amides for Selective Glucocorticoid Modulation

The patent applies local quality by designing glucocorticoid receptor modulators with specific molecular structures (formula I) that selectively activate anti-inflammatory pathways while avoiding pathways leading to adverse effects. The compounds are engineered to have differentiated interaction patterns with the glucocorticoid receptor, creating localized functional selectivity at the molecular level to achieve beneficial effects at specific biological targets while sparing other pathways.

The patent employs parameter changes by systematically varying molecular parameters of the glucocorticoid receptor modulators, including substituent groups (R1-R6), stereochemistry, and structural features. These parameter modifications enable fine-tuning of the compounds' selectivity profiles, allowing optimization of anti-inflammatory potency while minimizing activation of pathways associated with adverse effects such as metabolic disturbances and muscle wasting.